Page 1045 - medicina-integrativa_compress

1074 PARTE III, SECCIÓN 3 BIOQUÍMICA

133. Perloff WH: Treatment of the menopause. Am J Obstet Gynecol 159. Natta CL, Chen LC, Chow CK, et al: Selenium and glutathione
58:684-694, 1949. peroxidase levels in sickle cell anemia. Acta Haematol
134. London RS, Sundaram GS, Murphy L, et al: The effect of alpha- 83:130-132, 1990.
tocopherol on premenstrual symptomatology: A double-blind study 160. Karakucuk S, Ertugrul Mirza G, Faruk Ekinciler O, et al: Selenium
J Am Coll Nutr 2:115-122, 1983. concentrations in serum, lens and aqueous humour of patients with
135. Lohr JB, Cadet JL, Lohr MA, et al: Alpha-tocopherol in tardive senile cataract. Acta Ophthalmol Scand 73:329-332, 1995.
dyskinesia. Lancet 1(8358):913-914, 1987. 161. Arthur JR, Nicol F, Beckett GJ, et al: The role of selenium in thyroid
136. Ogunmekan AO, Hwang PA: A randomized, double-blind, placebo- hormone metabolism and effects of selenium deficiency on thyroid
controlled, clinical trial of D-alpha-tocopheryl acetate (vitamin E), as hormone and iodine metabolism. Biol Trace Elem Res 33:37-42,
add-on therapy, for epilepsy in children. Epilepsia 30:84-89, 1989. 1992.
137. Morris MC, Evans DA, Bienias JL, et al: Vitamin E and cognitive 162. Suadicani P, Hein HO, Gyntelberg F, et al: Serum selenium
decline in older persons. Arch Neurol 59:1125-1132, 2002. concentration and risk of ischaemic heart disease in a prospective
138. Traber MG, Sokol RJ, Ringel SP, et al: Lack of tocopherol in cohort study of 3000 males. Atherosclerosis 96:33-42, 1992.
peripheral nerves of vitamin E-deficient patients with peripheral 163. Clark LC, Hixson LJ, Combs GF Jr, et al: Plasma selenium
neuropathy. N Engl J Med 317:262-265, 1987. concentration predicts the prevalence of colorectal adenomatous
139. Masaki KH, Losonczy KG, Izmirlian G, et al: Association of vitamin polyps. Cancer Epidemiol Biomarkers Prev 2:41-46, 1993.
E and C supplement use with cognitive function and dementia in 164. Timbo BB, Tollefson L: Nutrition: A cofactor in HIV disease. J Am
elderly men. Neurology 54:1265-1272, 2000. Diet Assoc 94:1018-1022, 1994.
140. Ascherio A, Weisskopf MG, O’Reilly EJ, et al: Vitamin E intake and 165. Dworkin BM: Selenium deficiency in HIV infection and the acquired
risk of amyotrophic lateral sclerosis. Ann Neurol 57:104-110, 2005. immunodeficiency syndrome (AIDS). Chem Biol Interact 91:
141. Mune M, et al: Effect of vitamin E on lipid metabolism and 181-186, 1994.
atherosclerosis in ESRD patients. Kidney Int Suppl 71:S126-S129, 166. Finnerty EF: Topical zinc in the treatment of herpes simplex. Cutis
1999. 37:130-131, 1986.
142. Paolisso G, D’Amore A, Giugliano D, et al: Pharmacologic doses of 167. Engel ED: Diabetes mellitus: Impaired wound healing from zinc
vitamin E improve insulin action in healthy subjects and non-insulin- deficiency. J Am Podiatr Assoc 71:536-544, 1981.
dependent diabetic patients. Am J Clin Nutr 57:650-656, 1993. 168. Brodi I: Treatment of recurrent furunculosis with oral zinc. Lancet
143. Vezina D, Maufette F, Roberts KD, et al: Selenium-vitamin E 1(8052-8053):1358, 1977.
supplementation in infertile men: Effects on semen parameters and 169. Terwolbeck K, Purrmann J, Kuhn S, et al: Zinc in lymphocytes—the
micronutrient levels and distribution. Biol Trace Elem Res assessment of zinc status in patients with Crohn’s disease. J Trace
53:65-83, 1996. Elem Electrolytes Health Dis 6:117-121, 1992.
144. Palan PR, Mikail MS, Basu J, et al: Beta-carotene levels in exfoliated 170. Dronfield MW, Malone JD, Langman MJ, et al: Zinc in ulcerative
cervicovaginal epithelial cells in cervical intraepithelial neoplasia and colitis: A therapeutic trial and report on plasma levels. Gut
cervical cancer. Am J Obstet Gynecol 167:1899-1903, 1992. 18:33-36, 1977.
145. Stich HL, et al: Remission of oral leukoplakias and micronuclei in 171. Frommer DJ: The healing of gastric ulcers by zinc sulphate. Med J
tobacco/betel quid chewers treated with beta-carotene and with Aust 2:793-796, 1975.
beta-carotene plus vitamin A. Int J Cancer 42:195-199, 1988. 172. Johnson MA, Porter KH: Micronutrient supplementation and
146. Gann PH, Ma J, Giovannucci E, et al: Lower prostate cancer risk in infection in institutionalized elders. Nutr Rev 55:400-404, 1997.
men with elevated plasma lycopene levels: Results of a prospective 173. Meerarani P, Ramadass P, Toborek M: Zinc protects against
analysis. Cancer Res 59:1225-1230, 1999. apoptosis of endothelial cells induced by linoleic acid and tumor
147. Morris DL, Kritchevsky SB, Davis CE: Serum carotenoids and necrosis factor alpha. Am J Clin Nutr 71:81-87, 2000.
coronary heart disease. The Lipid Research Clinics Coronary 174. Newsome DA, Swartz M, Leone NC, et al: Oral zinc in macular
Primary Prevention Trial and Follow-up Study. JAMA 272: degeneration. Arch Ophthalmol 106:192-198, 1988.
1439-1441, 1994. 175. Simkin PA: Oral zinc sulphate in rheumatoid arthritis. Lancet
148. Agarwal S, Rao AV: Tomato lycopene and low density lipoprotein 2(7985):539-542, 1976.
oxidation: A human dietary intervention study. Lipids 33:981-984, 176. Gupta VL, Chaubey BS: Efficacy of oral zinc therapy in the
1998. management of sickle cell crises. Indian J Med Res 86:803-807, 1987.
149. Rissanen TH, Voutilainen S, Nyyssonen K, et al: Low serum 177. Hirt M, Nobel S, Barron E, et al: Zinc nasal gel for the treatment of
lycopene concentration is associated with an excess incidence of common cold symptoms: A double-blind, placebo-controlled trial.
acute coronary events and stroke: The Kuopio Ischaemic Heart Ear Nose Throat J 79:778-780, 2000.
Disease Risk Factor Study. Br J Nutr 85:749-754, 2001. 178. Mossad SB, Macknin ML, Medendorp SV, et al: Zinc gluconate
150. Landrum JT, Bone RA, Joa H, et al: A one year study of the macular lozenges for treating the common cold: A randomized, double-
pigment: The effect of 140 days of a lutein supplement. Exp Eye Res blind, placebo-controlled study. Ann Intern Med 125:81-88, 1996.
65:57-62, 1997. 179. Girodon F, Blache D, Monget AL, et al: Effect of a two-year
151. Seddon JM, Ajani UA, Sperduto RD, et al: Dietary carotenoids, supplementation with low doses of antioxidant vitamins and/or
vitamins A, C, and E and advanced age-related macular minerals in elderly subjects on levels of nutrients and antioxidant
degeneration. JAMA 272:1413-1420, 1994. defense parameters. J Am Coll Nutr 16:357-365, 1997.
152. Dwyer JH, Navab M, Dwyer KM, et al: Oxygenated carotenoid lutein 180. Richer S: Multicenter ophthalmic and nutritional age-related
and progression of early atherosclerosis: The Los Angeles macular degeneration study—part 2: Antioxidant intervention and
Atherosclerosis Study. Circulation 103:2922-2927, 2001. conclusions. J Am Optom Assoc 67:30-49, 1996.
153. Neuman I, Nahum H, Ben-Amotz A, et al: Reduction of exercise- 181. Greene L: Asthma and oxidant stress: Nutritional, environmental,
induced asthma oxidative stress by lycopene, a natural antioxidant. and genetic risk factors. J Am Coll Nutr 14:317-324, 1995.
Allergy 55:1184-1189, 2000. 182. Zandi PP, Anthony JC, Khachaturian AS, et al: Reduced risk of
154. Mack CP, Hultquist DE, Shlafer M, et al: Myocardial flavin Alzheimer disease in users of antioxidant vitamin supplements: The
reductase and riboflavin: A potential role in decreasing Cache County Study. Arch Neurol 61:82-88, 2004.
reoxygenation injury. Biochem Biophys Res Comm 212:35-40, 1995. 183. Chappell LC, Seed PT, Briley AL, et al: Effect of antioxidants on the
155. Venarucci D, Venarucci V, Vallese A, et al: Free radicals: Important occurrence of pre-eclampsia in women at increased risk: A
cause of pathologies refer to ageing. Panminerva Med 41: randomised trial. Lancet 354:810-816, 1999.
335-339, 1999. 184. Yokoyama K, Itoman M, Takagishi K, et al: Protective effects of
156. Holecek V, Liska J, Racek J, et al: [The significance of free radicals coenzyme Q10 on ischemia-induced reperfusion injury in ischemic
and antioxidants due to the load induced by sport activity]. Cesk limb models. Plast Reconstr Surg 90:890-898, 1992.
Fysiol 53:76-79, 2004. 185. Muller T, Buttner T, Gholipour AF, et al: Coenzyme Q10
157. Tarp U, Overad K, Hansen JC, et al: Low selenium level in severe supplementation provides mild symptomatic benefit in patients with
rheumatoid arthritis. Scand J Rheumatol 14:97-101, 1985. Parkinson’s disease. Neurosci Lett 341:201-204, 2003.
158. Rayman MP, Abou-Shakra FR, Ward NI, et al: Comparison of 186. Raschke P, Massoudy P, Becker BF, et al: Taurine protects the heart
selenium levels in pre-eclamptic and normal pregnancies. Biol Trace from neutrophil-induced reperfusion injury. Free Radic Biol Med
Elem Res 55:9-20, 1996. 19:461-471, 1995.